Cargando…
Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with poor prognosis and immune response, which plays an important role in tumor progression. Recently, immunotherapies have revolutionized the therapeutic means of malignancies including HNSCC. However, the relationship between imm...
Autores principales: | Sun, Jing, Fang, Guiqing, Zuo, Zhibin, Yu, Xijiao, Xue, Lande, Li, Chong, Li, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521413/ https://www.ncbi.nlm.nih.gov/pubmed/34657509 http://dx.doi.org/10.1177/15330338211045823 |
Ejemplares similares
-
TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2020) -
Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021) -
Identification of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma Based on Dysregulated Immune LncRNAs
por: Du, Yucong, et al.
Publicado: (2022) -
TGF-β Signaling Pathway-Based Model to Predict the Subtype and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Zheng, Lian, et al.
Publicado: (2022) -
TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma
por: Yang, Zheng, et al.
Publicado: (2020)